Report Summary
Eternity Insights has published a new study on Global Oxaliplatin Market focusing on key segments as by Type (Purity 98 %,Purity 99 %, Other), by Application (Oxaliplatin Injection,Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Oxaliplatin Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Oxaliplatin Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Oxaliplatin Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Oxaliplatin Market Segmentation:
Oxaliplatin Market, By Type
- Purity 98 %
- Purity 99 %
- Other
Oxaliplatin Market, By Application
- Oxaliplatin Injection
- Other
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Oxaliplatin market in terms of demand generation. The Oxaliplatin market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Oxaliplatin market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Oxaliplatin Market Taxonomy:
To learn more about this report
Global Oxaliplatin Market Competitive Landscape
The global Oxaliplatin market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Scion Pharm Taiwan
- Acebright
- Sai Phytoceuticals
- Nischem International
- Polymed Therapeutics
- Fresenius Kabi Oncology
- Tapi Teva
- Heraeus
- Shilpa Medicare Limited
- Vinkem Labs
- Chem Genix
- Cipla
- Qilu Pharmaceutial
- VUAB Pharma
- Berr Chemical
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Purity 98 %,Purity 99 %, Other |
| By Application Outlook |
Oxaliplatin Injection,Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Scion Pharm Taiwan,Acebright,Sai Phytoceuticals,Nischem International,Polymed Therapeutics,Fresenius Kabi Oncology,Tapi Teva,Heraeus,Shilpa Medicare Limited,Vinkem Labs,Chem Genix,Cipla,Qilu Pharmaceutial,VUAB Pharma,Berr Chemical |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
Global Oxaliplatin Market Report 2020, Forecast to 2027
1 Scope of the Study
1.1 Oxaliplatin Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 Oxaliplatin Industry Overview
2.1 Global Oxaliplatin Market Size (Million USD) Comparison by Regions (2020-2027)
2.1.1 Oxaliplatin Global Import Market Analysis
2.1.2 Oxaliplatin Global Export Market Analysis
2.1.3 Oxaliplatin Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 Purity ? 98 %
2.2.2 Purity ? 99 %
2.3.2 Other
2.4.2 Global Oxaliplatin Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Oxaliplatin Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Oxaliplatin Manufacturer Market Share
2.4.5 Top 10 Oxaliplatin Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Oxaliplatin Market
2.4.7 Key Manufacturers Oxaliplatin Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 Oxaliplatin Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
3 Upstream and Downstream Market Analysis
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Oxaliplatin Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 Global Oxaliplatin Market Size Categorized by Regions
4.1 Global Oxaliplatin Revenue, Sales and Market Share by Regions
4.1.1 Global Oxaliplatin Sales and Market Share by Regions (2015-2020)
4.1.2 Global Oxaliplatin Revenue and Market Share by Regions (2015-2020)
4.2 Europe Oxaliplatin Sales and Growth Rate (2015-2020)
4.3 APAC Oxaliplatin Sales and Growth Rate (2015-2020)
4.4 North America Oxaliplatin Sales and Growth Rate (2015-2020)
4.5 South America Oxaliplatin Sales and Growth Rate (2015-2020)
4.6 Middle East & Africa Oxaliplatin Sales and Growth Rate (2015-2020)
5 Europe Oxaliplatin Market Size Categorized by Countries
5.1 Europe Oxaliplatin Sales, Revenue and Market Share by Countries
5.1.1 Europe Oxaliplatin Sales by Countries (2015-2020)
5.1.2 Europe Oxaliplatin Revenue by Countries (2015-2020)
5.1.3 Germany Oxaliplatin Sales and Growth Rate (2015-2020)
5.1.4 UK Oxaliplatin Sales and Growth Rate (2015-2020)
5.1.5 France Oxaliplatin Sales and Growth Rate (2015-2020)
5.1.6 Russia Oxaliplatin Sales and Growth Rate (2015-2020)
5.1.7 Italy Oxaliplatin Sales and Growth Rate (2015-2020)
5.1.8 Spain Oxaliplatin Sales and Growth Rate (2015-2020)
5.2 Europe Oxaliplatin Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Oxaliplatin Sales, Revenue and Market Share by Type (2015-2020)
5.3.1 Europe Oxaliplatin Sales Market Share by Type (2015-2020)
5.3.2 Europe Oxaliplatin Revenue and Revenue Share by Type (2015-2020)
5.4 Europe Oxaliplatin Sales Market Share by Application (2015-2020)
6 Asia-Pacific Oxaliplatin Market Size Categorized by Countries
6.1 Asia-Pacific Oxaliplatin Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific Oxaliplatin Sales by Countries (2015-2020)
6.1.2 Asia-Pacific Oxaliplatin Revenue by Countries (2015-2020)
6.1.3 China Oxaliplatin Sales and Growth Rate (2015-2020)
6.1.4 Japan Oxaliplatin Sales and Growth Rate (2015-2020)
6.1.5 Korea Oxaliplatin Sales and Growth Rate (2015-2020)
6.1.6 India Oxaliplatin Sales and Growth Rate (2015-2020)
6.1.7 Southeast Asia Oxaliplatin Sales and Growth Rate (2015-2020)
6.1.8 Australia Oxaliplatin Sales and Growth Rate (2015-2020)
6.2 Asia-Pacific Oxaliplatin Sales and Revenue (Value) by Manufacturers (2018-2020)
6.3 Asia-Pacific Oxaliplatin Sales, Revenue and Market Share by Type (2015-2020)
6.3.1 Asia-Pacific Oxaliplatin Sales Market Share by Type (2015-2020)
6.3.2 Asia-Pacific Oxaliplatin Revenue and Revenue Share by Type (2015-2020)
6.4 Asia-Pacific Oxaliplatin Sales and Market Share by Application (2015-2020)
7 North America Oxaliplatin Market Size Categorized by Countries
7.1 North America Oxaliplatin Sales, Revenue and Market Share by Countries
7.1.1 North America Oxaliplatin Sales by Countries (2015-2020)
7.1.2 North America Oxaliplatin Revenue by Countries (2015-2020)
7.1.3 United States Oxaliplatin Sales and Growth Rate (2015-2020)
7.1.4 Canada Oxaliplatin Sales and Growth Rate (2015-2020)
7.1.5 Mexico Oxaliplatin Sales and Growth Rate (2015-2020)
7.2 North America Oxaliplatin Revenue (Value) by Manufacturers (2018-2020)
7.3 North America Oxaliplatin Sales, Revenue and Market Share by Type (2015-2020)
7.3.1 North America Oxaliplatin Sales Market Share by Type (2015-2020)
7.3.2 North America Oxaliplatin Revenue and Revenue Share by Type (2015-2020)
7.4 North America Oxaliplatin Sales Market Share by Application (2015-2020)
8 South America Oxaliplatin Market Size Categorized by Countries
8.1 South America Oxaliplatin Sales, Revenue and Market Share by Countries
8.1.1 South America Oxaliplatin Sales by Countries (2015-2020)
8.1.2 South America Oxaliplatin Revenue by Countries (2015-2020)
8.1.3 Brazil Oxaliplatin Sales and Growth Rate (2015-2020)
8.2 South America Oxaliplatin Revenue (Value) by Manufacturers (2018-2020)
8.3 South America Oxaliplatin Sales, Revenue and Market Share by Type (2015-2020)
8.3.1 South America Oxaliplatin Sales Market Share by Type (2015-2020)
8.3.2 South America Oxaliplatin Revenue and Revenue Share by Type (2015-2020)
8.4 South America Oxaliplatin Sales Market Share by Application (2015-2020)
9 Middle East and Africa Oxaliplatin Market Size Categorized by Countries
9.1 Middle East and Africa Oxaliplatin Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Oxaliplatin Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Oxaliplatin Revenue by Countries (2015-2020)
9.1.3 GCC Countries Oxaliplatin Sales and Growth Rate (2015-2020)
9.1.4 Turkey Oxaliplatin Sales and Growth Rate (2015-2020)
9.1.5 Egypt Oxaliplatin Sales and Growth Rate (2015-2020)
9.1.6 South Africa Oxaliplatin Sales and Growth Rate (2015-2020)
9.2 Middle East and Africa Oxaliplatin Revenue (Value) by Manufacturers (2018-2020)
9.3 Middle East and Africa Oxaliplatin Sales, Revenue and Market Share by Type
9.3.1 Middle East and Africa Oxaliplatin Sales Market Share by Type (2015-2020)
9.3.2 Middle East and Africa Oxaliplatin Revenue and Revenue Share by Type (2015-2020)
9.4 Middle East and Africa Oxaliplatin Sales Market Share by Application (2015-2020)
10 Global Oxaliplatin Market Segment by Type
10.1 Global Oxaliplatin Revenue, Sales and Market Share by Type (2015-2020)
10.1.1 Global Oxaliplatin Sales and Market Share by Type (2015-2020)
10.1.2 Global Oxaliplatin Revenue and Market Share by Type (2015-2020)
10.2 Purity ? 98 % Sales Growth Rate and Price
10.2.1 Global Purity ? 98 % Sales Growth Rate (2015-2020)
10.2.2 Global Purity ? 98 % Price (2015-2020)
10.3 Purity ? 99 % Sales Growth Rate and Price
10.3.1 Global Purity ? 99 % Sales Growth Rate (2015-2020)
10.3.2 Global Purity ? 99 % Price (2015-2020)
11.1 Global OxaliplatinSales Market Share by Application (2015-2020)
11.2 Oxaliplatin Injection Sales Growth Rate (2015-2020)
11.3 Other Sales Growth Rate (2015-2020)
12.1 Global Oxaliplatin Revenue, Sales and Growth Rate (2020-2027)
12.2 Oxaliplatin Market Forecast by Regions (2020-2027)
12.2.1 Europe Oxaliplatin Market Forecast (2020-2027)
12.2.2 APAC Oxaliplatin Market Forecast (2020-2027)
12.2.3 North America Oxaliplatin Market Forecast (2020-2027)
12.2.4 South America Oxaliplatin Market Forecast (2020-2027)
12.2.5 Middle East & Africa Oxaliplatin Market Forecast (2020-2027)
12.3 Oxaliplatin Market Forecast by Type (2020-2027)
12.3.1 Global Oxaliplatin Sales Forecast by Type (2020-2027)
12.3.2 Global Oxaliplatin Market Share Forecast by Type (2020-2027)
12.4 Oxaliplatin Market Forecast by Application (2020-2027)
12.4.1 Global Oxaliplatin Sales Forecast by Application (2020-2027)
12.4.2 Global Oxaliplatin Market Share Forecast by Application (2020-2027)
13 Analysis of Oxaliplatin Industry Key Manufacturers
13.1 Scion Pharm Taiwan
13.1.1 Company Details
13.1.2 Product Information
13.1.3 Scion Pharm Taiwan Oxaliplatin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.1.4 Main Business Overview
13.1.5 Scion Pharm Taiwan News
13.2 Acebright
13.2.1 Company Details
13.2.2 Product Information
13.2.3 Acebright Oxaliplatin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.2.4 Main Business Overview
13.2.5 Acebright News
13.3 Sai Phytoceuticals
13.3.1 Company Details
13.3.2 Product Information
13.3.3 Sai Phytoceuticals Oxaliplatin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.3.4 Main Business Overview
13.3.5 Sai Phytoceuticals News
13.4 Nischem International
13.4.1 Company Details
13.4.2 Product Information
13.4.3 Nischem International Oxaliplatin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.4.4 Main Business Overview
13.4.5 Nischem International News
13.5 Polymed Therapeutics
13.5.1 Company Details
13.5.2 Product Information
13.5.3 Polymed Therapeutics Oxaliplatin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.5.4 Main Business Overview
13.5.5 Polymed Therapeutics News
13.6 Fresenius Kabi Oncology
13.6.1 Company Details
13.6.2 Product Information
13.6.3 Fresenius Kabi Oncology Oxaliplatin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.6.4 Main Business Overview
13.6.5 Fresenius Kabi Oncology News
13.7 Tapi Teva
13.7.1 Company Details
13.7.2 Product Information
13.7.3 Tapi Teva Oxaliplatin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.7.4 Main Business Overview
13.7.5 Tapi Teva News
13.8 Heraeus
13.8.1 Company Details
13.8.2 Product Information
13.8.3 Heraeus Oxaliplatin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.8.4 Main Business Overview
13.8.5 Heraeus News
13.9 Shilpa Medicare Limited
13.9.1 Company Details
13.9.2 Product Information
13.9.3 Shilpa Medicare Limited Oxaliplatin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.9.4 Main Business Overview
13.9.5 Shilpa Medicare Limited News
13.10 Vinkem Labs
13.10.1 Company Details
13.10.2 Product Information
13.10.3 Vinkem Labs Oxaliplatin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.10.4 Main Business Overview
13.10.5 Vinkem Labs News
13.11 Chem Genix
13.11.1 Company Details
13.11.2 Product Information
13.11.3 Chem Genix Oxaliplatin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.11.4 Main Business Overview
13.11.5 Chem Genix News
13.12 Cipla
13.12.1 Company Details
13.12.2 Product Information
13.12.3 Cipla Oxaliplatin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.12.4 Main Business Overview
13.12.5 Cipla News
13.13 Qilu Pharmaceutial
13.13.1 Company Details
13.13.2 Product Information
13.13.3 Qilu Pharmaceutial Oxaliplatin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.13.4 Main Business Overview
13.13.5 Qilu Pharmaceutial News
13.14 VUAB Pharma
13.14.1 Company Details
13.14.2 Product Information
13.14.3 VUAB Pharma Oxaliplatin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.14.4 Main Business Overview
13.14.5 VUAB Pharma News
13.15 Berr Chemical
13.15.1 Company Details
13.15.2 Product Information
13.15.3 Berr Chemical Oxaliplatin Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.15.4 Main Business Overview
13.15.5 Berr Chemical News
15 Appendix
